In patients with severe asthma with eosinophilia in reslizumab clinical trials, high peripheral blood eosinophil levels are associated with low FEV<sub>1</sub> reversibility.

Allergy Asthma Clin Immunol · 2020 · PMC7168990 · PMID 32328116

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, numerical differences in treatment effect for FEV 1 between the EOS high/β 2 agonist reversibility low group and the remaining population did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.